LRMR
NASDAQ
$3.83
Larimar Therapeutics Inc (LRMR)
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. The company is headquartered in Bala Cynwyd, Pennsylvania.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $14.40 (+275.98%)
Market Cap
$396M
FCF 5Y CAGR
+21.52%
Free Cash Flow Yield
-28.45%
Beta (5Y)
1.56
Price Chart
Valuation
Market Cap$396M
P/B2.45
Profitability
EBITDA-$172M
EPS-$2.00
Financial Health
Free Cash Flow Yield-28.45%
Growth & Risk
EPS 5Y CAGR-8.46%
FCF 5Y CAGR+21.52%
Beta (5Y)1.56
Sharpe Ratio0.61